These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22002875)

  • 1. A clonal model for human CD8+ regulatory T cells: unrestricted contact-dependent killing of activated CD4+ T cells.
    Hu D; Liu X; Zeng W; Weiner HL; Ritz J
    Eur J Immunol; 2012 Jan; 42(1):69-79. PubMed ID: 22002875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cytolytic CD161- CD56+ regulatory CD8 T cells in human peripheral blood.
    Hu D; Weiner HL; Ritz J
    PLoS One; 2013; 8(3):e59545. PubMed ID: 23527216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation.
    Voo KS; Peng G; Guo Z; Fu T; Li Y; Frappier L; Wang RF
    Cancer Res; 2005 Feb; 65(4):1577-86. PubMed ID: 15735048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells.
    Kaur G; Goodall JC; Jarvis LB; Hill Gaston JS
    Mol Immunol; 2010; 48(1-3):321-32. PubMed ID: 20688398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells.
    Voo KS; Bover L; Harline ML; Weng J; Sugimoto N; Liu YJ
    J Immunol; 2014 Jul; 193(2):627-34. PubMed ID: 24928999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
    Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
    Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
    Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals.
    Cavani A; Nasorri F; Ottaviani C; Sebastiani S; De Pità O; Girolomoni G
    J Immunol; 2003 Dec; 171(11):5760-8. PubMed ID: 14634084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.
    Lim A; French MA; Price P
    J Acquir Immune Defic Syndr; 2009 Jul; 51(3):248-57. PubMed ID: 19363449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique phenotype of human tonsillar and in vitro-induced FOXP3+CD8+ T cells.
    Siegmund K; Rückert B; Ouaked N; Bürgler S; Speiser A; Akdis CA; Schmidt-Weber CB
    J Immunol; 2009 Feb; 182(4):2124-30. PubMed ID: 19201865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.
    Hamza E; Gerber V; Steinbach F; Marti E
    Immunology; 2011 Nov; 134(3):292-304. PubMed ID: 21977999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV-specific CD8+ T cell reactivation in transplant patients results in expansion of CD8+ type-1 regulatory T cells.
    Popescu I; Macedo C; Abu-Elmagd K; Shapiro R; Hua Y; Thomson AW; Morelli AE; Storkus WJ; Metes D
    Am J Transplant; 2007 May; 7(5):1215-23. PubMed ID: 17331111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms.
    Correale J; Rojany M; Weiner LP
    J Neuroimmunol; 1997 Dec; 80(1-2):47-64. PubMed ID: 9413259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of in vitro expansion of different human virus-specific FoxP3+ regulatory CD8+ T cells in chronic hepatitis C virus infection.
    Billerbeck E; Nakamoto N; Seigel B; Blum HE; Chang KM; Thimme R
    J Gen Virol; 2009 Jul; 90(Pt 7):1692-1701. PubMed ID: 19321758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells.
    Beauford SS; Kumari A; Garnett-Benson C
    BMC Immunol; 2020 Apr; 21(1):18. PubMed ID: 32299365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells.
    Khanolkar A; Fu Z; Underwood LJ; Bondurant KL; Rochford R; Cannon MJ
    J Immunol; 2003 Mar; 170(6):3187-94. PubMed ID: 12626577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of virus-specific CD4+ and CD8+ regulatory T cells induced by human herpesvirus 6 infection.
    Wang F; Chi J; Peng G; Zhou F; Wang J; Li L; Feng D; Xie F; Gu B; Qin J; Chen Y; Yao K
    J Virol; 2014 Jan; 88(2):1011-24. PubMed ID: 24198406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.
    Strauss L; Bergmann C; Whiteside TL
    J Immunol; 2009 Feb; 182(3):1469-80. PubMed ID: 19155494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.